Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated Porphyrin
- 15 January 2001
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (2) , 519-524
- https://doi.org/10.1200/jco.2001.19.2.519
Abstract
PURPOSE: To determine the recommended dose, toxicity profile, and pharmacokinetics of a novel boronated porphyrin (BOPP) for photodynamic therapy (PDT) of intracranial tumors. PATIENTS AND METHODS:...Keywords
This publication has 25 references indexed in Scilit:
- Plasma Pharmacokinetics and Tissue Biodistribution of Boron Following Administration of a Boronated Porphyrin in DogsJournal of Pharmaceutical Sciences, 2000
- Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are headingNeuro-Oncology, 1999
- Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are headingNeuro-Oncology, 1999
- Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994Neuro-Oncology, 1999
- Rapid Cage Degradation of 1-Formyl- and 1-Alkyloxycarbonyl-Substituted 1,2-Dicarba-closo-dodecaboranes by Water or Methanol in Polar Organic SolventsInorganic Chemistry, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Photodynamic therapy of brain tumorsSeminars in Surgical Oncology, 1995
- Stereotactic Intratumoral Photodynamic Therapy for Recurrent Malignant Brain TumorsNeurosurgery, 1991
- Photodynamic therapy of malignant brain tumoursLasers in Medical Science, 1990
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980